StockData
Grace Therapeutics, Inc. logo

Grace Therapeutics, Inc. (GRCE) stock

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.72−0.03 (-1.71%)

Close on Nov 17, 2026Market cap $36.18MP/E –Yield –

Grace Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Grace Therapeutics's profit margin for the twelve months ending Mar 31, 2022 was -9.8%. For fiscal 2022 it was -9.8%, against -10039.8% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Mar 31, 2022-9.8%+10030.0
FY2021Mar 31, 2021-10039.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2022CQ1 2022Mar 31, 2022-3.9%–
Q4 FY2021CQ1 2021Mar 31, 2021-4909.6%–
Q3 FY2021CQ4 2020Dec 31, 2020-3975.3%–

More Grace Therapeutics figures

See a number that looks wrong?